Multiple cellular pathways and surface receptors

The term 'Multiple cellular pathways and surface receptors' is a non-specific descriptor and does not refer to a single, canonical therapeutic target. In biological and pharmacological contexts, this phrase is often used to describe the broad, pleiotropic effects of a compound or a complex biological system involving various signal transduction cascades (such as the PI3K/Akt or MAPK pathways) and diverse membrane proteins (such as G protein-coupled receptors or ion channels). Because it lacks a specific molecular identity, gene symbol, or defined protein structure, it cannot be classified as a discrete target for drug development or regulatory approval. According to standard pharmacological definitions, a drug target must be a specific entity, typically a protein, whose activity is modified by a drug to produce a therapeutic effect (Santos et al., 2017, Nature Reviews Drug Discovery). Consequently, this entry is considered 'incorrect' as it provides too much generalized information without identifying a specific, actionable molecule.

Not applicable as this entry represents a broad category of biological entities rather than a specific molecular target.